China's Unitree has priced its initial public offering at a $9.04 billion valuation, marking the first mainland Chinese listing of a humanoid robot maker and signaling how the US-China technology competition is expanding beyond software into physical robotics. The Hangzhou-based company is raising 6.1 billion yuan (roughly $905 million) through the sale of 40.45 million new shares on Shanghai's STAR Market, with subscriptions set to open on August 10.

The IPO timing underscores a critical shift in how Beijing and Washington are competing in artificial intelligence. While much of the recent US-China tech rivalry has focused on semiconductor access and large language models, Unitree's public market debut reveals that China is aggressively moving into embodied AI, a field where robots physically interact with the real world. This represents a different battleground than the software-focused competition that has dominated headlines.

What Makes Unitree's Business Model Significant Right Now?

Unitree has experienced explosive growth in recent years, with revenue more than quadrupling to 1.7 billion yuan in 2025. Humanoid robots have become the company's largest business segment, generating 867.8 million yuan in sales and surpassing its earlier focus on four-legged robots. The company's robots are known for their acrobatic capabilities, including running, dancing, and complex movement sequences that demonstrate the sophistication of its AI and mechanical engineering.

However, growth has begun to moderate. In the first quarter of 2026, revenue rose 68.5% to 422.8 million yuan, but profit excluding one-off items fell 52.6% to 40.3 million yuan as the company increased spending on research and marketing. This slowdown reflects the competitive pressures and regulatory headwinds that Unitree faces, particularly in its largest overseas market.

How Are US Export Controls Reshaping the Robotics Race?

The geopolitical context surrounding Unitree's IPO cannot be overlooked. The United States has recently imposed new restrictions on foreign-made humanoid and four-legged robots, a direct response to escalating US-China trade and technology tensions. Washington has also tightened Chinese access to American technology and markets more broadly, while Beijing has responded with export curbs and sanctions on selected US entities.

Unitree's existing humanoid and four-legged robots currently have US approvals, but the company has acknowledged that future models could be barred from sale in America. This regulatory uncertainty is a significant risk factor for the company's growth strategy. According to its IPO prospectus, US sales accounted for 13.3% of Unitree's revenue last year, meaning that any loss of market access or approval for new products could materially impact the company's international expansion plans.

• Current US Market Exposure: The United States represented 13.3% of Unitree's revenue in 2025, making it a meaningful but not dominant revenue source.
• Regulatory Risks: Future humanoid robot models may face export restrictions or approval denials, limiting Unitree's ability to sell next-generation products in the US market.
• Supply Chain Vulnerabilities: The company relies on imported parts for manufacturing, and tariffs or supply chain disruptions could increase production costs and reduce profitability.
• Government Procurement Limits: Restrictions on government purchases of Chinese robotics could eliminate a significant customer segment in the US and allied nations.

The company's IPO prospectus explicitly warns that US tariffs, limits on government purchases, export controls, or the loss of existing approvals could hurt overseas growth and disrupt supplies of imported parts. This candid risk disclosure reflects the reality that Unitree's future depends not only on technological innovation but also on navigating an increasingly fragmented global technology landscape.

What Does DeepSeek's Investment in Unitree Reveal About China's AI Strategy?

One notable detail in Unitree's IPO filing is that Chinese AI company DeepSeek is among the strategic investors in the offering. DeepSeek, which has gained international attention for its large language model capabilities, is backing a robotics company, suggesting that China's leading AI firms are coordinating investments across the AI stack, from software to hardware to embodied systems. This vertical integration strategy contrasts with the more fragmented approach in the US, where AI software companies and robotics makers often operate independently.

Unitree plans to use the IPO proceeds to develop robot software and hardware, launch new products, and build a manufacturing base. This capital allocation strategy indicates that the company is preparing for a long-term competition in embodied AI, investing heavily in both the algorithmic and physical infrastructure needed to compete globally.

The broader implication is clear: as the US focuses on restricting Chinese access to advanced semiconductors and AI models, China is simultaneously building out its own ecosystem of robotics companies, AI software providers, and manufacturing capabilities. Unitree's $9 billion valuation and successful IPO suggest that Beijing's strategy of developing sovereign AI capabilities extends well beyond large language models into the physical world, where robots powered by AI will increasingly perform tasks in manufacturing, logistics, and other industries.